PRMT7 and hepatocellular carcinoma: In sum, these data indicate that the PRMT7 intronic region containing the HCC-susceptible variant rs73613962 has allele-specific enhancer activity, and the risk allele G of rs73613962 corresponds to higher enhancer activity as compared to the non-risk allele T.